Evidence map›Paper›PMID 41156647›Full record

ArticlePathogens (Basel, Switzerland)2025

Therapeutic Efficacy of an Anti-P116-661 Polyclonal Antibody Against

Yiting Zhang, Xinqi Geng, Yan Liu, Wenli Li, Feng Shao, Mengmeng Jin, Jinzhi Wang, Linding Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Host immune dysfunction and Mycoplasma pneumoniae immune evasion: dual drivers of pathogenesis in Mycoplasma pneumoniae pneumonia.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  2. Immune dysregulation inFrontiers in immunology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yiting ZhangAnhui Provincial Key Laboratory of Zoonoses, Department of Microbiology and Parasitology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
Xinqi GengAnhui Provincial Key Laboratory of Zoonoses, Department of Microbiology and Parasitology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
Yan LiuAnhui Provincial Key Laboratory of Zoonoses, Department of Microbiology and Parasitology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
Wenli LiAnhui Provincial Key Laboratory of Zoonoses, Department of Microbiology and Parasitology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
Feng ShaoDepartment of The Second Clinical School of Medicine, Anhui Medical University, Hefei 230032, China.
Mengmeng JinDepartment of The Second Clinical School of Medicine, Anhui Medical University, Hefei 230032, China.
Jinzhi WangDepartment of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
Linding WangAnhui Provincial Key Laboratory of Zoonoses, Department of Microbiology and Parasitology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.

Funding

Anhui Medical University 2023 Clinical Medicine ("5+3" integration) Major (Grade2022) Anhui Medical University 2023 Clinical Medicine ("5+3" integration) Major (Grade2022)Anhui Medical University 2024 Clinical Medicine ("5+3" integration) Major (Grade2023) "Early Contact Research" training Program (2024-ZQKY-174) Anhui Medical University 2024 Clinical Medicine ("5+3" integration) Major (Grade2023) "Early Contact Research" training Program"Early Contact Research" training Program (2023-ZQKY-156). "Early Contact Research" training Program (2023-ZQKY-156).Scientific Research Project of Higher Education Institutions in Anhui Province 2022AH040100the Scientific Research Fund of Anhui Institute of Translational Medicine 2022zhyx-C10
6 · The paper itself

Abstract

The aim of this study was to investigate the therapeutic potential of a polyclonal antibody against the

Indexed as

Antibodies, BacterialAntigens, BacterialMycoplasma pneumoniaePneumonia, MycoplasmaA549 CellsAnimalsBacterial AdhesionDisease Models, AnimalHumansInterleukin-6LungMiceRabbitsTumor Necrosis Factor-alphaAntibodies, BacterialAntigens, BacterialInterleukin-6Tumor Necrosis Factor-alphacell adhesionHE stainingIL-6Mycoplasma pneumoniae (MP)P116-661 polyclonal antibodyTNF-α

Identifiers

PMID41156647
PMCPMC12567429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.